Cea mai mare fabrică de penicilină din Europa riscă să fie închisă din cauza prețurilor reduse ale antibioticelor chinezești

The last major penicillin factory in Europe faces closure due to competition from cheaper Chinese antibiotics, impacting the Austrian facility's viability. EU governments prioritize cost-effective healthcare solutions, leading to increased reliance on imports from China. The share of Chinese imports in the EU's penicillin market has surged from 44% in 2019 to 86% last year. The pandemic highlighted Europe's dependency on Asian pharmaceutical supplies, prompting the EU to approve funding to boost production capacity at the Kundl factory by 20%.